Matthew P Miller is Chief Operating Officer of Oncology Institute, Inc.. Currently has a direct ownership of 242,992 shares of TOI, which is worth approximately $51,028. The most recent transaction as insider was on Mar 17, 2023, when has been sold 67,667 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K
0% 3M change
0% 12M change
Total Value Held $51,028

Matthew P Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2023
BUY
Grant, award, or other acquisition
-
67,667 Added 21.78%
242,992 Common Stock
Dec 16 2022
BUY
Open market or private purchase
$69,999 $0.95 p/Share
73,684 Added 29.59%
175,325 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
23,607 Added 18.85%
101,641 Common Stock
Nov 15 2022
SELL
Sale (or disposition) back to the issuer
$1,171 $2.03 p/Share
577 Reduced 0.73%
78,034 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
28,027 Added 26.28%
78,611 Common Stock
MPM

Matthew P Miller

Chief Operating Officer
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI